4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

NCT02115204 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2011

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Methotrexate
DRUG: 5-fluorouracil

Sponsor

West German Study Group

Collaborators

[object Object]